Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand ?
Open Access
- 1 January 2010
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 4, 1463
- https://doi.org/10.3389/fnins.2010.00032
Abstract
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that results in progressive loss of motoneurons, motor weakness and death within 3–5 years after disease onset. Therapeutic options remain limited despite substantial number of approaches that have been tested clinically. Many neurotrophic growth factors are known to promote the survival of neurons and foster regeneration in the central nervous system. Various neurotrophic factors have been investigated pre-clinically and clinically for the treatment of ALS. Although pre-clinical data appeared promising, no neurotrophic factors succeeded yet in a clinical phase III trial. In this review we discuss the rationale behind those factors, possible reasons for clinical failures, and argue for a renewal of hope in this powerful class of drugs for the treatment of ALS.Keywords
This publication has 100 references indexed in Scilit:
- Improving efficiency of ALS clinical trials using lead‐in designsAmyotrophic Lateral Sclerosis, 2004
- A novel role for an established player: anemia drug erythropoietin for the treatment of cerebral hypoxia/ischemiaTransfusion and Apheresis Science, 2004
- Recommendations for Advancing Development of Acute Stroke TherapiesStroke, 2003
- Recommendations for Clinical Trial Evaluation of Acute Stroke TherapiesStroke, 2001
- Neurotrophins Rapidly Modulate Growth Cone Response to the Axon Guidance Molecule, Collapsin-1Molecular and Cellular Neuroscience, 1998
- Acidic fibroblast growth factor prevents post-axotomy neuronal death of the newborn rat facial nerveNeuroscience Letters, 1995
- Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosisNature, 1995
- Neurotrophic agents prevent motoneuron death following sciatic nerve section in the neonatal mouseJournal of Neurobiology, 1994
- Activity‐Sensitive Signaling by Muscle‐Derived Insulin‐like Growth Factors in the Developing and Regenerating Neuromuscular SystemAnnals of the New York Academy of Sciences, 1993
- Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized ratsBiochemical and Biophysical Research Communications, 1984